Engineered glycoforms of an antineuroblastoma IgG1 with optimized antibody-dependent cellular cytotoxic activity

Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×

Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

Reff, M., Carner, K., Chambers, K., Chinn, P., Leonard, J., Raab, R., Newman, R., Hanna, N., & Anderson, D. (1994) · Blood · doi:10.1182/blood.v83.2.435.435 · Cited by 1,996

Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides

Schachter, H. (1986) · Biochemistry and Cell Biology · doi:10.1139/o86-026 · Cited by 526

Biosynthetic Controls That Determine the Branching and Microheterogeneity of Protein-Bound Oligosaccharides

Schachter, H. (1986) · Advances in experimental medicine and biology · doi:10.1007/978-1-4684-5209-9_2 · Cited by 510

Sequencing of N-Linked Oligosaccharides Directly from Protein Gels: In-Gel Deglycosylation Followed by Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry and Normal-Phase High-Performance Liquid Chromatography

Küster, B., Wheeler, S. F., Hunter, A. P., Dwek, R. A., & Harvey, D. J. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2199 · Cited by 358

Effect of glycosylation on antibody function: implications for genetic engineering

Wright, A. M., & Morrison, S. L. (1997) · Trends in biotechnology · doi:10.1016/s0167-7799(96)10062-7 · Cited by 317

Quantitative aspects of the matrix‐assisted laser desorption mass spectrometry of complex oligosaccharides

Harvey, D. J. (1993) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.1290070712 · Cited by 265

In Pursuit of the Optimal Fed‐Batch Process for Monoclonal Antibody Production

Bibila, T. A., & Robinson, D. K. (1995) · Biotechnology Progress · doi:10.1021/bp00031a001 · Cited by 251

Overlapping distribution of two glycosyltransferases in the Golgi apparatus of HeLa cells.

Nilsson, T., Pypaert, M., Hoe, M. H., Slusarewicz, P., Berger, E. G., & Warren, W. G. (1993) · The Journal of Cell Biology · doi:10.1083/jcb.120.1.5 · Cited by 222

Multiple interactions of IgG with its core oligosaccharide can modulate recognition by complement and human Fc γ receptor I and influence the synthesis of its oligosaccharide chains

Lund, J., Takahashi, N., Pound, J. D., Goodall, M. D., & Jefferis, R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.11.4963 · Cited by 216

Antibody Engineering in Translational Medicine

Fischer, E. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4372-7_11

Achieving Appropriate Glycosylation During the Scaleup of Antibody Production

Deng, X., Raju, T. S., & Morrow, K. J. (2004) · Springer eBooks · doi:10.1007/978-1-4419-8877-5_3

Regulation and Programming of Antibody Effector Function through IgG Glycosylation

Mahan, A. E. (2014) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)

Site-specific conjugation of tumour-targeting: antibodies using transglutaminase

Jeger, S. (2009) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-005963273 · Cited by 1

Functional Role of Glycosylation in a Human IgG4 Antibody Assessed by Surface Plasmon Resonance Technology

Wong, R. B., Zeng, M., Lee, A.-H., Raju, T. S., & Cheng, K. (2012) · The Open Pharmacology Journal · doi:10.2174/1874143601206010027

Emerging concepts in monocloal antibody therapy

Weiner, L. M. (2007) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(07)70092-7

Metabolic Engineering of Recombinant Plasminogen Sialylation in Animal Cells by Tetracycline-Regulated Expression of Murine CMP-NeuAc Synthetase and Hamster CMP-NeuAc Transporter Genes

Baker, K. N., Johnson, I. D., Roberts, G. P., Cook, A., Baines, A. J., Gerardy‐Schahn, R., & James, D. C. (2008) · Springer eBooks · doi:10.1007/0-306-46875-1_60

Biotechnological Applications of Artificial Microtissues

Sánchez-Bustamante, C. D. (2009) · TDX (Tesis Doctorals en Xarxa)

Improving protein therapeutics through quantitative molecular engineering approaches and a cell-based oral delivery platform

Ng, D. T. W. (2013) · Scholarly Commons (University of Pennsylvania)

Sphingolipids, ABC transporters and chemosensitivity in neuroblastoma

Dijkhuis, A. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)

Generation of an industrially ideal host cell line for producing completely-defucosylated antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC)

Satoh, M., Yamane‐Ohnuki, N., Mori, K., Niwa, R., Shinkawa, T., Imai, H., Kuni‐Kamochi, R., Nakano, R., Yamano, K., Kanda, Y., et al. (2006) · Springer eBooks · doi:10.1007/1-4020-4457-7_5

5. CONTROLLING CARBOHYDRATES ON RECOMBINANT GLYCOPROTEINS

Jenkins, N., Lund, J., & Monaco, L. (2002)

What Is a Biosimilar?

Neri, D. (2015) · Frontiers of gastrointestinal research · doi:10.1159/000381579

Engineered Antibody Derivatives in Preclinical and Clinical Development

Kellner, C., & Peipp, M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7107-3_10 · Cited by 1

Cellular Modification for the Improvement of the Glycosylation Pathway

KRUMMEN, L. A., & Weikert, S. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47525-1_4

Anti-human platelet antigen (HPA)-1a antibodies: For better or for worse

Eksteen, M. (2015) · NORA - Norwegian Open Research Archives

Mass spectrometric analysis of therapeutic proteins and complex biological samples

Liu, S. (2013) · Digital Repository Service (Northeastern University) · doi:10.17760/d20003083

Glycoengineering of Therapeutic Antibodies

Klein, C. (2012) · Arzneimittelforschung · doi:10.1055/s-0032-1324900

Therapeutic Monoclonal Antibodies: Attractions and Challenges

Khanna, N., Asaf, A., & Marg, A. (2002)

and PMN effector cells Antibody fucosylation differentially impacts cytotoxicity mediated by NK

Parren, P. W. H. I., Valerius, T., Dechant, M., Beyer, T. D., Repp, R., Vink, T., van de Winkel, J. G. J., Peipp, M., van Bueren, J. J. L., Schneider‐Merck, T., et al. (2009)

Monoclonal Antibody Analysis Using Microfluidic Technologies

Staples, G. O., Potter, O. G., & Yin, H. (2015) · ACS symposium series · doi:10.1021/bk-2015-1202.ch009

Optimizing the glycosylation of recombinant proteins

Rosenlöcher, J. (2016) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8398

Glycan characterization and manipulation using phospholipid additives for capillary electrophoresis

Archer‐Hartmann, S. A. (2012) · doi:10.33915/etd.4826

Engineering of synthetic mammalian gene networks and their cross-kingdom conservation

Gitzinger, M. (2010) · Repository for Publications and Research Data (ETH Zurich) · doi:10.3929/ethz-a-006425023

ADCC Enhancement Technologies for Next‐Generation Therapeutic Antibodies

Liu, C., & Yan, S. (2016) · doi:10.1002/9781118940648.ch20

LC-MS determination of glycosylation pattern on glycoproteins as critical quality attribute for biopharmaceuticals and potential markers for diseases

Zhang, A. (2015) · Digital Repository Service (Northeastern University) · doi:10.17760/d20195696

Expression and characterisation of biopharmaceuticals in heterologous expression systems

Paetz, A., & Fischer, R. (2005) · RWTH Publications (RWTH Aachen)

Signaling and Glycoproteins

Zhao, Y., Gu, J., & Taniguchi, N. (2007) · Elsevier eBooks · doi:10.1016/b978-044451967-2/00091-x

Cell Products: Antibodies

Birch, J. R. (2009) · Wiley eBooks · doi:10.1002/9780470054581.eib202

Chemotherapie-freie Behandlung von hämatologischen Neoplasien: Zukunftstraum oder beginnende Realität?

Ring, A., & Müller, A. M. S. (2019) · Praxis · doi:10.1024/1661-8157/a003230

Glycoengineering of Chinese Hamster Ovary cells for improving biotherapeutics’ efficacies.

Chung, C. (2016)

质谱鉴定内源性人FCγRIII的表征显示位点，等位基因和序列特异性糖基化* [S]

Washburn, N., 罗宾meccariello, Duffner, J. L., Getchell, K. M., Holte, K., 托马斯刺激了, Srinivasan, K., Prenovitz, R., 乔纳森·兰辛, Capila, I., et al. (2019)

The study of culture redox potential’s effect on glycosylation and production of monoclonal antibodies in mammalian cell cultures

Dionne, B. (2015) · Mspace (University of Manitoba)

Glycosylation

Spearman, M. A., Lattová, E., Perreault, H., & Butler, M. (2018) · Wiley eBooks · doi:10.1002/9781119378341.ch3

Recombinant expression systems

(2015) · CRC Press eBooks · doi:10.1201/b19077-7

Monoclonal Antibody Glycoengineering for Biopharmaceutical Quality Assurance

Gómez, I. A., & del Val, I. J. (2021) · Cell engineering · doi:10.1007/978-3-030-79871-0_6

Novel Antibody Interfaces Revealed Through Structural MiningPreprint

Yin, Y., Romei, M. G., Sankar, K., Pal, L. R., Hoi, K. H., Yang, Y., Leonard, B. C., Boenig, G. D. L., Kumar, N., Matsumoto, M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.06.487381

IgG glycans and glyco-engineering

(2012) · Elsevier eBooks · doi:10.1533/9781908818096.251

Faculty Opinions recommendation of Current progress in innovative engineered antibodies.

Abdiche, Y. N. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.729268838.793560915

Faculty Opinions recommendation of Fc-glycosylation of IgG1 is modulated by B-cell stimuli.

Williams, M. A., & Collin, M. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.9047958.10601054

Therapeutic Antibodies and Immunologic Conjugates

Cheung, N. V. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50038-5

N-glycans bring therapeutic antibody

Yonezawa, A. (2023) · Drug Delivery System · doi:10.2745/dds.38.297

Impacts of Antibody Structure and Mixtures on Receptor Signaling for Antibody-Dependent Cellular Cytotoxicity

Guan, J., Wang, T., Tessier, P. M., & Thurber, G. M. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01183-x

Asymmetrical Glyco-Engineering of Monoclonal Antibodies Provides Insights into α-Gal ImmunogenicityPreprint

Bosman, G. P., Ehlers, A. M., Buckley, T., Dobruchowska, J. M., Toraño, J. S., Bentlage, A. E. H., Knulst, A. C., Vidarsson, G., & Boons, G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.15.694461

Cell Line Engineering for Production of Therapeutic Antibody Glycoforms with Increased Biological Activity

Umaña, P., Brünker, P., Ferrara, C., Moser, S., Suter, T. B., Gerdes, C. A., Püntener, U., Jean-Mairet, J. J. P., Buholzer, P., & Spaeni, M. (2005) · Springer eBooks · doi:10.1007/1-4020-3103-3_82

Identifisering av en gruppe glykosyltransferaser som mulige målgener for transkripsjonsfaktoren Pax6

Nguyen, H.-L. T. (2009) · NORA - Norwegian Open Research Archives

Generative design of antibody Fc-variants with synthetic and programmable functional profilesPreprint

Irvine, E. B., Bikias, T., Stamkopoulos, E., Frei, L., Schürmann, N., Warrender, A. K., Schmid, H., Coukos, D., Yang, H., Minot, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.10.681689

An Efficient Workflow for CHO Cell Genome Engineering with OpenCRISPR-1Preprint

Kolakada, D., Ankala, R., Donatelli, J. L., & Smith, D. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.18.695036

Antibody glycosylation in neuroimmune diseases

Li, K., Luo, M., Xu, L., Ouyang, Y., Zhou, Q., Xiang, W., Ren, Y., Wen, Z., Shi, G., Luo, Z., et al. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07611-y

On the use of glycoengineering methods for the generation of antibodies with enhanced effector functions

Serafin, B., Henry, O., & Crescenzo, G. D. (2026) · Glycobiology · doi:10.1093/glycob/cwag019

Antioxidant excipient–mediated stabilization preserves FcγRIIIa binding and ADCC activity of rituximab

Narvekar, A., Tathe, U., Puranik, A., Kulkarni, B. J., Jagtap, D. D., Jain, R. D., & Dandekar, P. P. (2026) · Biologicals · doi:10.1016/j.biologicals.2026.101883

Variants de la portion Fc des IgG : Cartographie et analyse brevets, confrontation aux biomédicaments en développement et proposition d'une nouvelle nomenclature

Pottier, J. (2016) · theses.fr (ABES) · doi:10.70675/0ebdf162z31a3z4cb4z8a13z11354657e93c

Mise en oeuvre de dosages pour le diagnostic précoce de l'hypothyroïdie

Iss, C. (2015) · theses.fr (ABES) · doi:10.70675/f9f2aeebza5a8z4cf3zb9afzd52e7504b286

Déterminants moléculaires de la pharmacocinétique des anticorps thérapeutiques

Brachet, G. (2017) · theses.fr (ABES) · doi:10.70675/8a131ef8z9b1az469fzb97aze35914486b73

Insights into TMEM165 function in Golgi glycosylation and lysosomal Mn-induced degradation

Lebredonchel, E. (2020) · theses.fr (ABES) · doi:10.70675/eb458818z3679z4757za808z7bc3c043d612

Ingénierie métabolique de la voie de N-Glycosylation chez la diatomée Phaeodactylum tricornutum

Dumontier, R. (2020) · theses.fr (ABES) · doi:10.70675/28ff391ez6f2fz496fz93dbzfbd714683c09

Analyse et exploitation des données associées aux variants d’IgG décrits dans les brevets : paysage brevet des variants d'anticorps IgG4 à activité antagoniste et mise au point d'un modèle de prédiction d'affinité pour FcRn par apprentissage machine

Dumet, C. (2020) · theses.fr (ABES) · doi:10.70675/5a9ec911z0a71z4e28zbe61za14331956923

Chemoenzymatic synthesis of unusual antibody glycoforms using E. coli expressed human and bovine β-1,4-galactosyltransferase and their mutants

Owitipana, D. N., Harris, D., Yun, H., Zong, G., & Wang, L. (2026) · Carbohydrate Research · doi:10.1016/j.carres.2026.110019

Subclass switching enhances protective efficacy of a non-neutralizing H7N9 avian influenza antibody

Dou, Y., Zhao, J., He, X., Song, S.-U., Tseren-Ochir, E.-O., Song, C., Liu, X., Hu, J., & Hu, Z. (2026) · Veterinary Microbiology · doi:10.1016/j.vetmic.2026.111171

Relative quantitation strategy of glycans in tocilizumab labeled based on mass spectrometry probes d0/d15-CEBTPP: Monitoring glycan changes in rat serum

Wang, S., Cong, S., Ding, C., Li, X., Piao, G., & Min, J. Z. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101787

Glycan-intrinsic monoclonal antibody biomanufacturing

Gyorgypal, A. (2026) · Frontiers in Chemical Engineering · doi:10.3389/fceng.2026.1955792

Catalytic Chain Transfer Photopolymerization (CCTP2): A New Approach for the Fabrication of Multi-Materials Author

Jones, M. (2026) · doi:10.56902/etdcrp.2026.162

Transition metal ions and their oxide nanoparticles differentially regulate CHO cell growth, metabolism, and N-glycosylation

Yu, C., 姚雪静, Tian, Z., Gao, Y., 汪世龙, Jiang, C., & Liu, Q. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1978281

Controlling Carbohydrates on Reconbinant Glycoproteins

Jenkins, N., Lund, J., & Monaco, L. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-47525-1_5

Influence of Variable N-Glycosylation on the Cytolytic Potential of Chimeric CD19 Antibodies

Barbin, K., Stieglmaier, J., Saul, D., Stieglmaier, K., Stockmeyer, B., Pfeiffer, M. M., Lang, P., & Fey, G. H. (2006) · Journal of Immunotherapy · doi:10.1097/01.cji.0000175684.28615.7b · Cited by 28

Expression of GnTIII in a recombinant anti‐CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FCγRIII

Davies, J., Jiang, L., Pan, L., LaBarre, M. J., Anderson, D., & Reff, M. (2001) · Biotechnology and Bioengineering · doi:10.1002/bit.1119 · Cited by 327

Modulation of therapeutic antibody effector functions by glycosylation engineering: Influence of Golgi enzyme localization domain and co‐expression of heterologous β1, 4‐N‐acetylglucosaminyltransferase III and Golgi α‐mannosidase II

Ferrara, C., Brünker, P., Suter, T., Moser, S., Püntener, U., & Umaña, P. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20777 · Cited by 305

Improved Effector Functions of a Therapeutic Monoclonal Lewis Y-Specific Antibody by Glycoform Engineering

Schuster, M., Umaña, P., Ferrara, C., Brünker, P., Gerdes, C. A., Waxenecker, G., Wiederkum, S., Schwager, C., Loibner, H., Himmler, G., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4212 · Cited by 91

Engineering of protein glycosylation in Chinese hamster ovary cells

Umaña, P. (2005) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/6ceh-kt92 · Cited by 1